WebApr 6, 2024 · Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market. MONTREAL, April 26, 2024 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, developmen... 1 year ago - … WebMONTREAL, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a …
SBFM looking ready to rocket - there are warrants …
WebFeb 15, 2024 · Each unit consists of one share of common stock, par value $0.001 per share, and two warrants, each warrant exercisable for one share of common stock. The … WebSunshine Biopharma, Inc (SBFM) SEC Filing 10-K Annual Report for the fiscal year ending Saturday, December 31, 2024 Home SEC Filings Sunshine Biopharma, Inc (SBFM) 10-K … c++ string tokenize
Sunshine Biopharma, Inc. Announces Pricing of $8 Million Public Offeri…
WebJan 25, 2024 · Since than SBFM has been rapidly developing its covid-19 treatment recently announcing it has received the fourth tranche of funding under the recently announced committed minimum financing of $2,000,000 with RB Capital Partners Inc. This brings the total to $1,050,000 that the Company has received to date under this financing. WebFeb 17, 2024 · At the closing, the Company issued an aggregate of 1,882,353 common shares and 4,102,200 warrants to purchase common shares. The Company’s common … WebMar 11, 2024 · Sunshine Biopharma (SBFM) warrants each have an activity cost of $2.22, dependent upon changes in that. The warrant has a term equivalent to a long time from the issuance date. SBFM offer is relied upon to close approximately March 14, 2024, dependent upon the fulfillment of standard shutting conditions. More From Stocks telegraph Investing dj jamaika tô só observando